Laxative management in ambulatory cancer patients on opioid therapy: A prospective, open-label investigation of polyethylene glycol, sodium picosulphate and lactulose

European Journal of Cancer Care

Volumn 21, Issue 1, 2012, Pages 131-140

  Wirz, S ^a   Nadstawek, J ^b   Elsen, C ^b   Junker, U ^c   Wartenberg, H C ^d  

^a Palliative Medicine CURA Hospital   (Germany)

^b UNIVERSITY OF BONN   (Germany)

^c RUHR UNIVERSITY BOCHUM   (Germany)

^d UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Cancer; Constipation; Opioid; Pain; Supportive care; Symptoms

Indexed keywords

LACTULOSE; LAXATIVE; MACROGOL DERIVATIVE; NARCOTIC ANALGESIC AGENT; PICOLINE DERIVATIVE; PICOSULFATE SODIUM;

AGED; ARTICLE; CHEMICALLY INDUCED DISORDER; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HOSPITALIZATION; HUMAN; INCIDENCE; MIDDLE AGED; NEOPLASM; PROSPECTIVE STUDY; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL;

AGED; ANALGESICS, OPIOID; CATHARTICS; CONSTIPATION; FEMALE; HUMANS; INCIDENCE; LACTULOSE; LAXATIVES; MIDDLE AGED; NEOPLASMS; PICOLINES; POLYETHYLENE GLYCOLS; PROSPECTIVE STUDIES; QUALITY OF LIFE; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX;

EID: 84155167316     PISSN: 09615423     EISSN: 13652354     Source Type: Journal    
DOI: 10.1111/j.1365-2354.2011.01286.x     Document Type: Article

References (41)

1. Aaronson, N.K., Ahmedzai S., Bergman B., Bullinger M., Cull A., Duez NJ., Filiberti A., Flechtner H., Fleishman S.B., de Haes J.C., Kaasa S., Klees M., Osoba D., Razavi D., Rofe P., Schraub S., Sneeuw K., Sullivan M. & Takeda F. (1993) The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. Journal of the National Cancer Institute 85, 365-376.
2. Agachan F., Chen T., Pfeifer J., Reissman P. & Wexner S.D. (1996) A constipation scoring system to simplify evaluation and management of constipated patients. Diseases of the Colon and Rectum 39, 681-685.
3. Agra Y., Sacristan A., Gonzalez M., Ferrari M., Portugues A. & Calvo M.J. (1998) Efficacy of senna versus lactulose in terminal cancer patients treated with opioids. Journal of Pain and Symptom Management 15, 1-7.
4. Ahmedzai S. & Brooks D. (1997) Transdermal fentanyl versus sustained-release oral morphine in cancer pain: preference, efficacy, and quality of life. The TTS-Fentanyl Comparative Trial Group. Journal of Pain and Symptom Management 13, 254-261.
5. Avila J.G. (2004) Pharmacologic treatment of constipation in cancer patients. Cancer Control 11 (Suppl. 3), 10-18.
6. Bennett M. & Cresswell H. (2003) Factors influencing constipation in advanced cancer patients: a prospective study of opioid dose, dantron dose and physical functioning. Palliative Medicine 17, 418-422.
7. Bouvy M.L., Buurma H. & Egberts T.C. (2002) Laxative prescribing in relation to opioid use and the influence of pharmacy-based intervention. Journal of Clinical Pharmacological Therapy 27, 107-110.
8. Bruera E., Kuehn N., Miller M.J., Selmser P. & Macmillan K. (1991) The Edmonton Symptom Assessment System (ESAS): a simple method for the assessment of palliative care patients. Journal of Palliative Care 7, 6-9.
9. Bruera E., Suarez-Almazor M., Velasco A., Bertolino M., MacDonald S.M. & Hanson J. (1994) The assessment of constipation in terminal cancer patients admitted to a palliative care unit: a retrospective review. Journal of Pain and Symptom Management 9, 515-519.
10. Davies E.C., Green C.F., Mottram D.R. & Pirmohamed M. (2008) The use of opioids and laxatives, and incidence of constipation, in patients requiring neck-of-femur (NOF) surgery: a pilot study. Journal of Clinical Pharmacological Therapy 33, 561-566.
11. Droney J., Ross J., Gretton S., Welsh K., Sato H. & Riley J. (2008) Constipation in cancer patients on morphine. Supportive Care in Cancer 16, 453-459.
12. Drossman D.A. & Dumitrascu D.L. (2006) Rome III: new standard for functional gastrointestinal disorders. Journal of Gastrointestinal and Liver Diseases 15, 237-241.
13. Fallon M.T. & Hanks G.W. (1999) Morphine, constipation and performance status in advanced cancer patients. Palliative Medicine 13, 159-160.
14. Freye E. & Latasch L. (2000) Effects of tramadol and tilidine/naloxone on oral-caecal transit and pupillary light reflex. Arzneimittel-Forschung 50, 24-30.
15. Glare P., Walsh D. & Sheehan D. (2006) The adverse effects of morphine: a prospective survey of common symptoms during repeated dosing for chronic cancer pain. American Journal of Hospice and Palliative Care 23, 229-235.
16. Jouët P., Sabate J.M., Flourie B., Cuillerier E., Gambini D., Lemann M., Jian R. & Coffin B. (2008) Effects of therapeutic doses of lactulose vs. polyethylene glycol on isotopic colonic transit. Alimentary Pharmacology and Therapeutics 27, 988-993.
17. Lawlor P., Turner K., Hanson J. & Bruera E. (1997) Dose ratio between morphine and hydromorphone in patients with cancer pain: a retrospective study. Pain 72, 79-85.
18. Levy M.H. (2003) Management of opioid-induced bowel dysfunction. The Journal of the National Comprehensive Cancer Network 1 (Suppl. 3), 522-526.
19. Mancini I.L., Hanson J., Neumann C.M. & Bruera E.D. (2000) Opioid type and other clinical predictors of laxative dose in advanced cancer patients: a retrospective study. Journal of Palliative Medicine 3, 49-56.
20. Max E.K., Hernandez J.J., Sturpe D.A. & Zuckerman I.H. (2007) Prophylaxis for opioid-induced constipation in elderly long-term care residents: a cross-sectional study of medicare beneficiaries. The American Journal of Geriatric Pharmacotherapy 5, 129-136.
21. McMillan S.C. (2004) Assessing and managing opiate-induced constipation in adults with cancer. Cancer Control 11 (Suppl. 3), 3-9.
22. McShane R.E. & McLane A.M. (1985) Constipation. Consensual and empirical validation. The Nursing Clinics of North America 20, 801-808.
23. Mercadante S., Casuccio A., Fulfaro F., Groff L., Boffi R., Villari P., Gebbia V. & Ripamonti C. (2001) Switching from morphine to methadone to improve analgesia and tolerability in cancer patients: a prospective study. Journal of Clinical Oncology 19, 2898-2904.
24. Mercadante S., Costanzo B.V., Fusco F., Buttà V., Vitrano V. & Casuccio A. (2009) Breakthrough pain in advanced cancer patients followed at home: a longitudinal study. Journal of Pain and Symptom Management 38, 554-560.
25. Miles C.L., Fellowes D., Goodman M.L. & Wilkinson S. (2006) Laxatives for the management of constipation in palliative care patients. Cochrane Database of Systematic Reviews. Issue 4, Art. No.: CD003448. DOI: 10.1002/14651858.CD003448.pub2.
26. National Health Service Fife Area Drug and Therapeutics Committee (2004) Guidelines for the control of constipation in adult patients with cancer. Cancer Control 11 (Suppl. 3), 24-25.
27. Oken M.M., Creech R.H., Tormey D.C., Horton J., Davis T.E., McFadden E.T. & Carbone P.P. (1982) Toxicity and response criteria of the Eastern Cooperative Oncology Group. American Journal of Clinical Oncology 5, 649-655.
28. Papagallo M. (2001) Incidence, prevalence, and management of opioid bowel dysfunction. American Journal of Surgery 182 (Suppl. 5A), 11-18.
29. Parsons H.A., de la Cruz M., El Osta B., Li Z., Calderon B., Palmer J.L. & Bruera E. (2010) Methadone initiation and rotation in the outpatient setting for patients with cancer pain. Cancer 116, 520-528.
30. Pereira J., Lawlor P., Vigano A., Dorgan M. & Bruera E. (2001) Equianalgesic dose ratios for opioids. a critical review and proposals for long-term dosing. Journal of Pain and Symptom Management 22, 672-687.
31. Portenoy R.K. (1987) Constipation in the cancer patient: causes and management. The Medical Clinics of North America 71, 303-311.
32. Potter J., Hami F., Bryan T. & Quigley C. (2003) Symptoms in 400 patients referred to palliative care services: prevalence and patterns. Palliative Medicine 17, 310-314.
33. Schoorl J. & Zylicz Z. (1997) Laxative policy for terminal patients ineffective. Nederlands tijdschrift voor geneeskunde 26, 823-826.
34. Staats P.S., Markowitz J. & Schein J. (2004) Incidence of constipation associated with long-acting opioid therapy: a comparative study. Southern Medical Journal 97, 129-134.
35. Sykes N.P. (1996) A volunteer model for the comparison of laxatives in opioid-related constipation. Journal of Pain and Symptom Management 11, 363-369.
36. Sykes N.P. (1998) The relationship between opioid use and laxative use in terminally ill cancer patients. Palliative Medicine 12, 375-382.
37. Tassinari D., Sartori S., Tamburini E., Scarpi E., Raffaeli W., Tombesi P. & Maltoni M. (2008) Adverse effects of transdermal opiates treating moderate-severe cancer pain in comparison to long-acting morphine: a meta-analysis and systematic review of the literature. Journal of Palliative Medicine 11, 492-501.
38. Twycross R.G., McNamara P., Schuijt C., Kamm M.A. & Jordan C. (2006) Sodium picosulfate in opioid-induced constipation: results of an open-label, prospective, dose-ranging study. Palliative Medicine 20, 419-423.
39. Walsh T.D. (1990) Prevention of opioid side effects. Journal of Pain and Symptom Management 5, 362-367.
40. Wirz S. & Klaschik E. (2005) Management of constipation in palliative care patients undergoing opioid therapy: is polyethylene glycol an option? American Journal of Hospice and Palliative Care 22, 375-381.
41. Wirz S., Wittmann M., Schenk M., Schroeck A., Schaefer N., Mueller M., Standop J., Kloecker N. & Nadstawek J. (2009) Gastrointestinal symptoms under opioid therapy: a prospective comparison of oral sustained-release hydromorphone, transdermal fentanyl, and transdermal buprenorphine. European Journal of Pain 13, 737-743.